Approved vaccination with third dose of Pfizer mRNA SARS-coV2 vaccine to adolescentsvaged 12 to 17 years; Immunocompromised persons who have received CoronaVac + CoronaVac Pfizer_BioNtech + Pfizer-BioNtech: Fifth dose of Pfizer mRNA platform vaccine to 6 months after last dose; Immunocompromised

Administer modified Ankara virus vaccine (Jynneos™️). Pre-exposure vaccination: 0.5 mL subcutaneous dose with a 2-dose schedule, 28-day interval to laboratory personnel handling samples for MPX dg.